First Drug-Coated Balloon IDE: A Conversation With Lutonix CEO Dennis Wahr

Following a four-year effort with FDA, Minneapolis start-up Lutonix recently met its goal to become the first company to gain an investigational device exemption for a drug-coated balloon.